AB Science S.A. (EPA:AB)
France
· Delayed Price · Currency is EUR 1.288
-0.008 (-0.62%)
At close: Mar 6, 2026
AB Science Revenue
AB Science had revenue of 515.00K EUR in the half year ending June 30, 2025, with 14.96% growth. This brings the company's revenue in the last twelve months to 1.03M, down -5.08% year-over-year. In the year 2024, AB Science had annual revenue of 1.07M with 10.52% growth.
Revenue (ttm)
1.03M
Revenue Growth
-5.08%
P/S Ratio
92.05
Revenue / Employee
28.53K
Employees
36
Market Cap
94.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.07M | 102.00K | 10.52% |
| Dec 31, 2023 | 970.00K | 12.00K | 1.25% |
| Dec 31, 2022 | 958.00K | -649.00K | -40.39% |
| Dec 31, 2021 | 1.61M | 24.00K | 1.52% |
| Dec 31, 2020 | 1.58M | 12.00K | 0.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Adocia | 12.88M |
| Sensorion | 5.65M |
| ABIONYX Pharma | 4.33M |
| Crossject Société Anonyme | 4.07M |